NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2,194 Cr | ₹1,751 Cr | ₹912 Cr | ₹264 Cr | ₹604 Cr |
What is the latest Operating Profit of NATCO PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹2,194 Cr |
| Mar2025 | ₹1,751 Cr |
| Mar2024 | ₹912 Cr |
| Mar2023 | ₹264 Cr |
| Mar2022 | ₹604 Cr |
How is Operating Profit of NATCO PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,194 Cr | 25.26 | |
| Mar2025 | ₹1,751 Cr | 92.10 | |
| Mar2024 | ₹912 Cr | 246.00 | |
| Mar2023 | ₹264 Cr | -56.36 | |
| Mar2022 | ₹604 Cr | - | |
Compare Operating Profit of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,362.5 Cr | -1.6% | -3.2% | -1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -1.6% |
-3.2% |
-1.5% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses